nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—Macular oedema—Niacin—atherosclerosis	0.0236	0.0448	CcSEcCtD
Fluocinolone Acetonide—Panophthalmitis—Pravastatin—atherosclerosis	0.0233	0.0441	CcSEcCtD
Fluocinolone Acetonide—Common cold—Pravastatin—atherosclerosis	0.0218	0.0413	CcSEcCtD
Fluocinolone Acetonide—Fungal skin infection—Niacin—atherosclerosis	0.0138	0.0262	CcSEcCtD
Fluocinolone Acetonide—Endophthalmitis—Pravastatin—atherosclerosis	0.0119	0.0226	CcSEcCtD
Fluocinolone Acetonide—Skin hyperpigmentation—Niacin—atherosclerosis	0.00971	0.0184	CcSEcCtD
Fluocinolone Acetonide—Eye irritation—Lovastatin—atherosclerosis	0.00787	0.0149	CcSEcCtD
Fluocinolone Acetonide—Glaucoma—Niacin—atherosclerosis	0.00767	0.0145	CcSEcCtD
Fluocinolone Acetonide—Viral infection—Ezetimibe—atherosclerosis	0.0073	0.0138	CcSEcCtD
Fluocinolone Acetonide—Rash pustular—Niacin—atherosclerosis	0.00724	0.0137	CcSEcCtD
Fluocinolone Acetonide—Cataract—Lovastatin—atherosclerosis	0.00706	0.0134	CcSEcCtD
Fluocinolone Acetonide—Neck pain—Ezetimibe—atherosclerosis	0.00667	0.0126	CcSEcCtD
Fluocinolone Acetonide—Cataract—Simvastatin—atherosclerosis	0.00661	0.0125	CcSEcCtD
Fluocinolone Acetonide—Gastroenteritis—Rosuvastatin—atherosclerosis	0.0065	0.0123	CcSEcCtD
Fluocinolone Acetonide—Viral infection—Pravastatin—atherosclerosis	0.00629	0.0119	CcSEcCtD
Fluocinolone Acetonide—Cataract—Pravastatin—atherosclerosis	0.00597	0.0113	CcSEcCtD
Fluocinolone Acetonide—Dermatitis contact—Niacin—atherosclerosis	0.00571	0.0108	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—PLA2G1B—atherosclerosis	0.00512	0.454	CrCbGaD
Fluocinolone Acetonide—Eczema—Simvastatin—atherosclerosis	0.00508	0.00962	CcSEcCtD
Fluocinolone Acetonide—Influenza—Rosuvastatin—atherosclerosis	0.00498	0.00943	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Lovastatin—atherosclerosis	0.00488	0.00925	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Ezetimibe—atherosclerosis	0.00479	0.00907	CcSEcCtD
Fluocinolone Acetonide—Eczema—Niacin—atherosclerosis	0.00466	0.00884	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00428	0.00811	CcSEcCtD
Fluocinolone Acetonide—Influenza—Lovastatin—atherosclerosis	0.00422	0.00799	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Rosuvastatin—atherosclerosis	0.00416	0.00789	CcSEcCtD
Fluocinolone Acetonide—Influenza—Ezetimibe—atherosclerosis	0.00414	0.00784	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Pravastatin—atherosclerosis	0.00413	0.00782	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Rosuvastatin—atherosclerosis	0.00399	0.00757	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.00384	0.00728	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Pravastatin—atherosclerosis	0.00369	0.00699	CcSEcCtD
Fluocinolone Acetonide—Infestation—Ezetimibe—atherosclerosis	0.00369	0.00699	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Ezetimibe—atherosclerosis	0.00369	0.00699	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00367	0.00695	CcSEcCtD
Fluocinolone Acetonide—Influenza—Niacin—atherosclerosis	0.00362	0.00686	CcSEcCtD
Fluocinolone Acetonide—Influenza—Pravastatin—atherosclerosis	0.00357	0.00676	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Lovastatin—atherosclerosis	0.00353	0.00668	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Rosuvastatin—atherosclerosis	0.00349	0.00661	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Ezetimibe—atherosclerosis	0.00346	0.00656	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00331	0.00628	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Simvastatin—atherosclerosis	0.0033	0.00625	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00325	0.00616	CcSEcCtD
Fluocinolone Acetonide—Cough—Rosuvastatin—atherosclerosis	0.00303	0.00573	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00298	0.00565	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Pravastatin—atherosclerosis	0.00298	0.00565	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Lovastatin—atherosclerosis	0.00298	0.00565	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—PLA2G1B—atherosclerosis	0.00298	0.264	CrCbGaD
Fluocinolone Acetonide—Arthralgia—Rosuvastatin—atherosclerosis	0.00295	0.00559	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Ezetimibe—atherosclerosis	0.00293	0.00554	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Niacin—atherosclerosis	0.00291	0.00551	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Ezetimibe—atherosclerosis	0.0029	0.0055	CcSEcCtD
Fluocinolone Acetonide—Erythema—Ezetimibe—atherosclerosis	0.00288	0.00546	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Ezetimibe—atherosclerosis	0.00288	0.00546	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Lovastatin—atherosclerosis	0.00288	0.00545	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Pravastatin—atherosclerosis	0.00286	0.00542	CcSEcCtD
Fluocinolone Acetonide—Back pain—Lovastatin—atherosclerosis	0.00284	0.00539	CcSEcCtD
Fluocinolone Acetonide—Infection—Rosuvastatin—atherosclerosis	0.00281	0.00533	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Niacin—atherosclerosis	0.00279	0.00529	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Simvastatin—atherosclerosis	0.00279	0.00529	CcSEcCtD
Fluocinolone Acetonide—Back pain—Ezetimibe—atherosclerosis	0.00279	0.00528	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00278	0.00526	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Lovastatin—atherosclerosis	0.00277	0.00525	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Simvastatin—atherosclerosis	0.00277	0.00524	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Pravastatin—atherosclerosis	0.00275	0.00521	CcSEcCtD
Fluocinolone Acetonide—Erythema—Simvastatin—atherosclerosis	0.00275	0.00521	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Niacin—atherosclerosis	0.00271	0.00513	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Simvastatin—atherosclerosis	0.00269	0.0051	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Lovastatin—atherosclerosis	0.00264	0.005	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Simvastatin—atherosclerosis	0.00259	0.00491	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00258	0.00489	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Niacin—atherosclerosis	0.00256	0.00485	CcSEcCtD
Fluocinolone Acetonide—Erythema—Niacin—atherosclerosis	0.00252	0.00478	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Niacin—atherosclerosis	0.00252	0.00478	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Pravastatin—atherosclerosis	0.00252	0.00478	CcSEcCtD
Fluocinolone Acetonide—Cough—Ezetimibe—atherosclerosis	0.00252	0.00477	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Lovastatin—atherosclerosis	0.0025	0.00474	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Simvastatin—atherosclerosis	0.00247	0.00468	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Ezetimibe—atherosclerosis	0.00245	0.00465	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Pravastatin—atherosclerosis	0.00243	0.00461	CcSEcCtD
Fluocinolone Acetonide—Pain—Rosuvastatin—atherosclerosis	0.00242	0.00459	CcSEcCtD
Fluocinolone Acetonide—Infection—Lovastatin—atherosclerosis	0.00238	0.00451	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Niacin—atherosclerosis	0.00238	0.00451	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Pravastatin—atherosclerosis	0.00234	0.00444	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Simvastatin—atherosclerosis	0.00234	0.00443	CcSEcCtD
Fluocinolone Acetonide—Infection—Ezetimibe—atherosclerosis	0.00234	0.00443	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Ezetimibe—atherosclerosis	0.00231	0.00437	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Niacin—atherosclerosis	0.00227	0.0043	CcSEcCtD
Fluocinolone Acetonide—Oedema—Simvastatin—atherosclerosis	0.00224	0.00425	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Pravastatin—atherosclerosis	0.00223	0.00423	CcSEcCtD
Fluocinolone Acetonide—Infection—Simvastatin—atherosclerosis	0.00223	0.00422	CcSEcCtD
Fluocinolone Acetonide—Cough—Niacin—atherosclerosis	0.0022	0.00417	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00219	0.00414	CcSEcCtD
Fluocinolone Acetonide—Cough—Pravastatin—atherosclerosis	0.00217	0.00411	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Niacin—atherosclerosis	0.00215	0.00407	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00214	0.00406	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Pravastatin—atherosclerosis	0.00212	0.00401	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00209	0.00395	CcSEcCtD
Fluocinolone Acetonide—Oedema—Niacin—atherosclerosis	0.00206	0.0039	CcSEcCtD
Fluocinolone Acetonide—Pain—Lovastatin—atherosclerosis	0.00205	0.00389	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00204	0.00387	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00203	0.00385	CcSEcCtD
Fluocinolone Acetonide—Oedema—Pravastatin—atherosclerosis	0.00203	0.00384	CcSEcCtD
Fluocinolone Acetonide—Infection—Pravastatin—atherosclerosis	0.00201	0.00382	CcSEcCtD
Fluocinolone Acetonide—Pain—Ezetimibe—atherosclerosis	0.00201	0.00381	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Rosuvastatin—atherosclerosis	0.002	0.00379	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00194	0.00367	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Rosuvastatin—atherosclerosis	0.00194	0.00367	CcSEcCtD
Fluocinolone Acetonide—Pain—Simvastatin—atherosclerosis	0.00192	0.00363	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Lovastatin—atherosclerosis	0.0019	0.00359	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00188	0.00356	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Rosuvastatin—atherosclerosis	0.00187	0.00355	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Ezetimibe—atherosclerosis	0.00186	0.00352	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00185	0.0035	CcSEcCtD
Fluocinolone Acetonide—Rash—Rosuvastatin—atherosclerosis	0.00178	0.00338	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Rosuvastatin—atherosclerosis	0.00178	0.00338	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Niacin—atherosclerosis	0.00178	0.00337	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Simvastatin—atherosclerosis	0.00177	0.00336	CcSEcCtD
Fluocinolone Acetonide—Headache—Rosuvastatin—atherosclerosis	0.00177	0.00336	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Lovastatin—atherosclerosis	0.00177	0.00335	CcSEcCtD
Fluocinolone Acetonide—Pain—Niacin—atherosclerosis	0.00176	0.00334	CcSEcCtD
Fluocinolone Acetonide—Pain—Pravastatin—atherosclerosis	0.00173	0.00329	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Ezetimibe—atherosclerosis	0.00173	0.00328	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Lovastatin—atherosclerosis	0.0017	0.00321	CcSEcCtD
Fluocinolone Acetonide—Nausea—Rosuvastatin—atherosclerosis	0.00168	0.00318	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Ezetimibe—atherosclerosis	0.00166	0.00315	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Simvastatin—atherosclerosis	0.00165	0.00313	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Lovastatin—atherosclerosis	0.00164	0.00311	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Niacin—atherosclerosis	0.00163	0.00309	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Ezetimibe—atherosclerosis	0.00161	0.00305	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Pravastatin—atherosclerosis	0.0016	0.00304	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Simvastatin—atherosclerosis	0.00159	0.00301	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Lovastatin—atherosclerosis	0.00159	0.003	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Ezetimibe—atherosclerosis	0.00156	0.00295	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Simvastatin—atherosclerosis	0.00153	0.00291	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Lovastatin—atherosclerosis	0.00152	0.00289	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Niacin—atherosclerosis	0.00152	0.00288	CcSEcCtD
Fluocinolone Acetonide—Rash—Lovastatin—atherosclerosis	0.00151	0.00287	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Lovastatin—atherosclerosis	0.00151	0.00286	CcSEcCtD
Fluocinolone Acetonide—Headache—Lovastatin—atherosclerosis	0.0015	0.00285	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Ezetimibe—atherosclerosis	0.0015	0.00283	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Pravastatin—atherosclerosis	0.00149	0.00283	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Simvastatin—atherosclerosis	0.00148	0.00281	CcSEcCtD
Fluocinolone Acetonide—Rash—Ezetimibe—atherosclerosis	0.00148	0.00281	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Ezetimibe—atherosclerosis	0.00148	0.00281	CcSEcCtD
Fluocinolone Acetonide—Headache—Ezetimibe—atherosclerosis	0.00147	0.00279	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Niacin—atherosclerosis	0.00146	0.00276	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Pravastatin—atherosclerosis	0.00143	0.00272	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Simvastatin—atherosclerosis	0.00143	0.0027	CcSEcCtD
Fluocinolone Acetonide—Nausea—Lovastatin—atherosclerosis	0.00142	0.0027	CcSEcCtD
Fluocinolone Acetonide—Rash—Simvastatin—atherosclerosis	0.00141	0.00268	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Simvastatin—atherosclerosis	0.00141	0.00268	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Niacin—atherosclerosis	0.00141	0.00267	CcSEcCtD
Fluocinolone Acetonide—Headache—Simvastatin—atherosclerosis	0.00141	0.00266	CcSEcCtD
Fluocinolone Acetonide—Nausea—Ezetimibe—atherosclerosis	0.0014	0.00265	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Pravastatin—atherosclerosis	0.00139	0.00263	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Niacin—atherosclerosis	0.00136	0.00258	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Pravastatin—atherosclerosis	0.00134	0.00254	CcSEcCtD
Fluocinolone Acetonide—Nausea—Simvastatin—atherosclerosis	0.00133	0.00252	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—NOS2—atherosclerosis	0.00133	0.118	CrCbGaD
Fluocinolone Acetonide—Vomiting—Niacin—atherosclerosis	0.00131	0.00248	CcSEcCtD
Fluocinolone Acetonide—Rash—Niacin—atherosclerosis	0.0013	0.00246	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Niacin—atherosclerosis	0.0013	0.00246	CcSEcCtD
Fluocinolone Acetonide—Headache—Niacin—atherosclerosis	0.00129	0.00244	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Pravastatin—atherosclerosis	0.00129	0.00244	CcSEcCtD
Fluocinolone Acetonide—Rash—Pravastatin—atherosclerosis	0.00128	0.00242	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Pravastatin—atherosclerosis	0.00128	0.00242	CcSEcCtD
Fluocinolone Acetonide—Headache—Pravastatin—atherosclerosis	0.00127	0.00241	CcSEcCtD
Fluocinolone Acetonide—Nausea—Niacin—atherosclerosis	0.00122	0.00232	CcSEcCtD
Fluocinolone Acetonide—Nausea—Pravastatin—atherosclerosis	0.0012	0.00228	CcSEcCtD
Fluocinolone Acetonide—Triamcinolone—PTGS2—atherosclerosis	0.000802	0.0711	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SELE—atherosclerosis	0.000692	0.0015	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HRH1—atherosclerosis	0.000692	0.0015	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—atherosclerosis	0.000684	0.00148	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.000678	0.00147	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—AGT—atherosclerosis	0.000676	0.00147	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—LEP—atherosclerosis	0.000662	0.00144	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.000657	0.00142	CbGpPWpGaD
Fluocinolone Acetonide—Betamethasone—PTGS2—atherosclerosis	0.000656	0.0582	CrCbGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—MMP9—atherosclerosis	0.000653	0.00142	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000652	0.00142	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LDLRAP1—atherosclerosis	0.000645	0.0014	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PDGFB—atherosclerosis	0.00064	0.00139	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—atherosclerosis	0.000636	0.00138	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.00063	0.00137	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—VWF—atherosclerosis	0.000617	0.00134	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PLTP—atherosclerosis	0.000606	0.00132	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—APOA1—atherosclerosis	0.000605	0.00131	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—atherosclerosis	0.00059	0.00128	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—F7—atherosclerosis	0.000588	0.00128	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—F2—atherosclerosis	0.000577	0.00125	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—PPARG—atherosclerosis	0.000577	0.00125	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Endothelins—AKT1—atherosclerosis	0.000575	0.00125	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—atherosclerosis	0.000569	0.00124	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.000568	0.00123	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—INS—atherosclerosis	0.000566	0.00123	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—MAPK8—atherosclerosis	0.000565	0.00122	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000562	0.00122	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—atherosclerosis	0.00056	0.00121	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000558	0.00121	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000555	0.0012	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—AKT1—atherosclerosis	0.000554	0.0012	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CG—atherosclerosis	0.000552	0.0012	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Endoderm Differentiation—TGFB1—atherosclerosis	0.000551	0.0012	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—IGF1—atherosclerosis	0.000547	0.00119	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—atherosclerosis	0.000543	0.00118	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000542	0.00118	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—TGFB1—atherosclerosis	0.000538	0.00117	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCG8—atherosclerosis	0.000526	0.00114	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LTA4H—atherosclerosis	0.000526	0.00114	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PLAT—atherosclerosis	0.000525	0.00114	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—SERPINE1—atherosclerosis	0.00052	0.00113	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000519	0.00113	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—STAT3—atherosclerosis	0.000516	0.00112	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—IGF1—atherosclerosis	0.000506	0.0011	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCL4—atherosclerosis	0.0005	0.00108	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—MAPK3—atherosclerosis	0.000493	0.00107	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.00049	0.00106	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—atherosclerosis	0.000489	0.00106	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—SERPINE1—atherosclerosis	0.00048	0.00104	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—ALB—atherosclerosis	0.000479	0.00104	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	0.000471	0.00102	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—KNG1—atherosclerosis	0.00046	0.000999	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PLAUR—atherosclerosis	0.000456	0.00099	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PLG—atherosclerosis	0.000446	0.000968	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—UTS2—atherosclerosis	0.000446	0.000967	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000437	0.000948	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SOD1—atherosclerosis	0.000428	0.000928	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CX3CR1—atherosclerosis	0.000427	0.000927	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CASR—atherosclerosis	0.000427	0.000927	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CX3CL1—atherosclerosis	0.000419	0.000909	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCG1—atherosclerosis	0.000415	0.000901	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	0.000409	0.000888	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HRH1—atherosclerosis	0.000409	0.000886	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IGF2—atherosclerosis	0.000406	0.000881	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—IL6—atherosclerosis	0.000406	0.00088	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	0.000402	0.000873	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—PARP1—atherosclerosis	0.000402	0.000872	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CNR2—atherosclerosis	0.000397	0.000862	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—APOB—atherosclerosis	0.000394	0.000855	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—FABP4—atherosclerosis	0.000391	0.000847	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LCAT—atherosclerosis	0.000391	0.000847	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOA4—atherosclerosis	0.000383	0.000832	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—PTGS2—atherosclerosis	0.000382	0.0339	CrCbGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—ESR2—atherosclerosis	0.000381	0.000826	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.00038	0.000825	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP7A1—atherosclerosis	0.000377	0.000817	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	0.000371	0.000806	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PRKCG—atherosclerosis	0.000366	0.000794	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000365	0.000792	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000359	0.000779	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CD36—atherosclerosis	0.000358	0.000776	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—atherosclerosis	0.000357	0.000775	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—STAT3—atherosclerosis	0.000354	0.000768	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	0.000351	0.000762	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP27A1—atherosclerosis	0.000348	0.000755	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000343	0.000744	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCL3—atherosclerosis	0.000342	0.000741	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	0.000341	0.000739	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.00034	0.000738	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000334	0.000725	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	0.000333	0.000722	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	0.00033	0.000717	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALOX5AP—atherosclerosis	0.00033	0.000716	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PLA2G2A—atherosclerosis	0.00033	0.000716	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOA2—atherosclerosis	0.00033	0.000716	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALOX15—atherosclerosis	0.00033	0.000716	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PDGFB—atherosclerosis	0.00033	0.000716	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—atherosclerosis	0.00033	0.000715	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TGFB1—atherosclerosis	0.000328	0.000712	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MMP1—atherosclerosis	0.000326	0.000707	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCG5—atherosclerosis	0.000326	0.000707	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000326	0.000706	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOA4—atherosclerosis	0.000321	0.000696	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	0.000318	0.00069	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LPA—atherosclerosis	0.000315	0.000683	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CAV1—atherosclerosis	0.000313	0.000678	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	0.000313	0.000678	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—APOA1—atherosclerosis	0.000312	0.000677	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.000309	0.00067	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCR2—atherosclerosis	0.000309	0.00067	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—EDNRA—atherosclerosis	0.000309	0.00067	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TNF—atherosclerosis	0.000306	0.000665	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—BGN—atherosclerosis	0.000305	0.000662	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	0.000303	0.000658	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000303	0.000657	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOA5—atherosclerosis	0.000302	0.000655	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GHRL—atherosclerosis	0.000301	0.000653	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—F2—atherosclerosis	0.000298	0.000646	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCL4—atherosclerosis	0.000295	0.000641	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NOS2—atherosclerosis	0.000294	0.000638	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000293	0.000636	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PLA2G1B—atherosclerosis	0.000291	0.00063	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000287	0.000623	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CG—atherosclerosis	0.000285	0.000618	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000285	0.000618	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000284	0.000616	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALOX5—atherosclerosis	0.000281	0.000609	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOA2—atherosclerosis	0.000276	0.000599	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000265	0.000574	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—KNG1—atherosclerosis	0.000264	0.000573	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—UTS2—atherosclerosis	0.000263	0.000571	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AGTR1—atherosclerosis	0.000263	0.00057	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IGF1—atherosclerosis	0.000261	0.000566	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000259	0.000562	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—PPARA—atherosclerosis	0.000255	0.000553	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CASR—atherosclerosis	0.000252	0.000548	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CX3CR1—atherosclerosis	0.000252	0.000548	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NAMPT—atherosclerosis	0.000252	0.000546	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.00025	0.000543	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LIPC—atherosclerosis	0.00025	0.000543	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOC3—atherosclerosis	0.000249	0.000539	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SERPINE1—atherosclerosis	0.000248	0.000537	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CX3CL1—atherosclerosis	0.000248	0.000537	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—IL6—atherosclerosis	0.000247	0.000536	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—ALB—atherosclerosis	0.000247	0.000536	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LDLR—atherosclerosis	0.000247	0.000536	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CETP—atherosclerosis	0.000241	0.000524	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	0.000237	0.000514	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NOS3—atherosclerosis	0.000236	0.000513	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CNR2—atherosclerosis	0.000235	0.000509	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MMP3—atherosclerosis	0.000234	0.000508	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SCARB1—atherosclerosis	0.000231	0.000501	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—ESR1—atherosclerosis	0.000231	0.000501	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000225	0.000488	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—EDN1—atherosclerosis	0.000223	0.000483	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCL5—atherosclerosis	0.000221	0.000479	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HMGCR—atherosclerosis	0.000218	0.000473	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—HSPA1B—atherosclerosis	0.000217	0.000471	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000214	0.000464	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	0.000211	0.000457	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—PPARG—atherosclerosis	0.000211	0.000457	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PRKCG—atherosclerosis	0.00021	0.000456	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VWF—atherosclerosis	0.000209	0.000454	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOC3—atherosclerosis	0.000208	0.000451	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LDLR—atherosclerosis	0.000207	0.000448	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCL3—atherosclerosis	0.000202	0.000438	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000197	0.000427	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCA1—atherosclerosis	0.000195	0.000422	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PARP1—atherosclerosis	0.000194	0.00042	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NCF1—atherosclerosis	0.000193	0.000419	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—SERPINE1—atherosclerosis	0.00019	0.000412	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AGT—atherosclerosis	0.000185	0.000401	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—ESR2—atherosclerosis	0.000183	0.000398	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EDNRA—atherosclerosis	0.000182	0.000396	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCR2—atherosclerosis	0.000182	0.000396	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CYBA—atherosclerosis	0.000182	0.000394	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GHRL—atherosclerosis	0.000178	0.000386	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PLAT—atherosclerosis	0.000178	0.000386	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PARP1—atherosclerosis	0.000178	0.000386	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—F2—atherosclerosis	0.000171	0.000371	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—VEGFA—atherosclerosis	0.00017	0.00037	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HMOX1—atherosclerosis	0.000167	0.000362	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CG—atherosclerosis	0.000163	0.000355	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MAPK3—atherosclerosis	0.000161	0.00035	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOB—atherosclerosis	0.00016	0.000347	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TGFB1—atherosclerosis	0.000156	0.000339	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KNG1—atherosclerosis	0.000156	0.000339	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTM1—atherosclerosis	0.000155	0.000337	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AGTR1—atherosclerosis	0.000155	0.000337	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LPL—atherosclerosis	0.000153	0.000331	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCL2—atherosclerosis	0.000152	0.00033	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PLG—atherosclerosis	0.000151	0.000328	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GPX1—atherosclerosis	0.000149	0.000323	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SIRT1—atherosclerosis	0.000148	0.00032	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CD36—atherosclerosis	0.000145	0.000315	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SOCS3—atherosclerosis	0.000143	0.000311	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MMP3—atherosclerosis	0.000138	0.0003	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF2—atherosclerosis	0.000138	0.000299	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—MTHFR—atherosclerosis	0.000137	0.000298	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPARA—atherosclerosis	0.000135	0.000293	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOB—atherosclerosis	0.000134	0.00029	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EDN1—atherosclerosis	0.000132	0.000285	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AGT—atherosclerosis	0.000131	0.000283	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCL5—atherosclerosis	0.000131	0.000283	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOE—atherosclerosis	0.000128	0.000278	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LPL—atherosclerosis	0.000128	0.000277	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CAV1—atherosclerosis	0.000127	0.000275	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOA1—atherosclerosis	0.000126	0.000274	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKCG—atherosclerosis	0.000124	0.000269	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PPARA—atherosclerosis	0.000123	0.000266	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SPP1—atherosclerosis	0.000121	0.000262	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CXCL8—atherosclerosis	0.00012	0.000261	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CG—atherosclerosis	0.000115	0.000251	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PDGFB—atherosclerosis	0.000112	0.000243	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPARG—atherosclerosis	0.000111	0.000242	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—ESR1—atherosclerosis	0.000111	0.000241	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—INS—atherosclerosis	0.000109	0.000237	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AGT—atherosclerosis	0.000109	0.000237	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—AKT1—atherosclerosis	0.000109	0.000236	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LEP—atherosclerosis	0.000107	0.000232	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOE—atherosclerosis	0.000107	0.000232	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CAV1—atherosclerosis	0.000106	0.00023	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOA1—atherosclerosis	0.000106	0.000229	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ESR1—atherosclerosis	0.000102	0.000222	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PPARG—atherosclerosis	0.000101	0.00022	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—F2—atherosclerosis	0.000101	0.000219	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALB—atherosclerosis	0.0001	0.000217	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CG—atherosclerosis	9.65e-05	0.000209	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NOS3—atherosclerosis	9.58e-05	0.000208	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MAPK3—atherosclerosis	9.25e-05	0.000201	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—INS—atherosclerosis	9.14e-05	0.000198	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SERPINE1—atherosclerosis	9.14e-05	0.000198	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCL2—atherosclerosis	8.99e-05	0.000195	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF1—atherosclerosis	8.84e-05	0.000192	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS2—atherosclerosis	8.77e-05	0.00019	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SERPINE1—atherosclerosis	8.39e-05	0.000182	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOS3—atherosclerosis	8.01e-05	0.000174	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCL8—atherosclerosis	7.11e-05	0.000154	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL6—atherosclerosis	6.76e-05	0.000147	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MMP9—atherosclerosis	6.43e-05	0.00014	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NFKB1—atherosclerosis	6.36e-05	0.000138	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAPK8—atherosclerosis	6.25e-05	0.000136	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT1—atherosclerosis	6.24e-05	0.000135	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MAPK3—atherosclerosis	5.94e-05	0.000129	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VEGFA—atherosclerosis	5.77e-05	0.000125	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—STAT3—atherosclerosis	5.72e-05	0.000124	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAPK3—atherosclerosis	5.46e-05	0.000119	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TGFB1—atherosclerosis	5.3e-05	0.000115	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKT1—atherosclerosis	4.41e-05	9.56e-05	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AKT1—atherosclerosis	4.01e-05	8.7e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL6—atherosclerosis	3.99e-05	8.66e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT1—atherosclerosis	3.68e-05	7.99e-05	CbGpPWpGaD
